Risedronate Sodium
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
60723-041 -
Package NDC
60723-041-04 -
Package NDC
60723-041-12 -
Application number
ANDA207516 -
SPL ID
460cdef1-681b-7ae4-e063-6294a90a1d55 -
SPL set ID
d60a56cb-ef49-4447-9043-7b6879a20d75 -
UNII
HU2YAQ274O -
RxCUI
905024 -
RxCUI
905092 -
RxCUI
905100
What the source publishes
- Labeler
- Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
- Active ingredients
- Risedronate Sodium
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Risedronate Sodium",
"splId": "460cdef1-681b-7ae4-e063-6294a90a1d55",
"labels": [
{
"setId": "d60a56cb-ef49-4447-9043-7b6879a20d75",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d60a56cb-ef49-4447-9043-7b6879a20d75",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d60a56cb-ef49-4447-9043-7b6879a20d75"
}
],
"routes": [
"ORAL"
],
"labeler": "Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BLISTER PACK in 1 CARTON (60723-041-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)",
"package_ndc": "60723-041-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20190401"
},
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (60723-041-12) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)",
"package_ndc": "60723-041-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20190401"
}
],
"productId": "60723-041_460cdef1-681b-7ae4-e063-6294a90a1d55",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "60723-041",
"deaSchedule": null,
"genericName": "Risedronate Sodium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RISEDRONATE SODIUM HEMI-PENTAHYDRATE",
"strength": "35 mg/1"
}
],
"applicationNumber": "ANDA207516",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190401",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"HU2YAQ274O"
],
"rxcui": [
"905024",
"905092",
"905100"
],
"spl_set_id": [
"d60a56cb-ef49-4447-9043-7b6879a20d75"
],
"manufacturer_name": [
"Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:60723-041_460cdef1-681b-7ae4-e063-6294a90a1d55"